Pediatric peripheral blood progenitor cell collection: Haemonetics MCS 3P versus COBE spectra verus fresenius AS104

Transfusion

Volumn 38, Issue 1, 1998, Pages 70-74

  Bambi, F ^a,b   Faulkner, L B ^a   Azzari, C ^a   Gelli, A M G ^a   Tamburini, A ^a   Tintori, V ^a   Lippi, A A ^a   Tucci, F ^a   Bernini, G ^a   Genovese, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; CELL SELECTION; CONTAMINATION; CYTOFLUOROMETRY; HEMODYNAMICS; HUMAN; HUMAN CELL; QUANTITATIVE DIAGNOSIS; STATISTICAL ANALYSIS; STEM CELL; THROMBOCYTE COUNT;

EID: 0031890035     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38198141501.x     Document Type: Article

References (17)

1. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992;9:277-84.
2. Hartman O, Blaise D, Michon J, et al. Results of a multicentric randomized clinical trial comparing peripheral blood stem cells and bone marrow graft in autologous transplantation (abstract). Blood 1995;86(Suppl 1):1821a.
3. Henon PR. Comparative cost analysis of autologous blood cell transplantation and autologous bone marrow transplantation (abstract). Blood 1994;84(Suppl 1):335a.
4. Woronoff-Lemsi MC, Limat S, Deconinck E, et al. Cost comparative study of peripheral blood progenitor cells and autologous bone marrow transplantation for lymphoma patients (abstract). Blood 1995;86(Suppl 1):822a.
5. Ross AA, Cooper BW, Lazarus HM, et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993;82:2605-10.
6. Miyajima Y, Horibe K, Fukuda M, et al. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 1996;77:1214-9.
7. Passos-Coelho JL, Ross AA, Moss TJ, et al. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 1995;85:1138-43.
8. Pettengell R, Woll PJ, Thatcher N, et al. Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 1995;13:148-56.
9. Shea TC, Mason JR, Storniolo AM, et al. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusion of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol 1992;10:464-73.
10. Kevy SV, Fosburg M. Therapeutic apheresis in childhood. J Clin Apheresis 1990;5:87-90.
11. Kasprisin DO. Techniques, indications, and toxicity of therapeutic hemapheresis in children. J Clin Apheresis 1989;5:21-4.
12. Mehta J, Powels R, Cabral S, et al. Comparison of COBE Spectra and Haemonetics MCS-3P cell separators for harvesting pripheral blood stem cells (abstract). Blood 1994;84(Suppl 1):2935a.
13. Demeocq F, Kanold J, Chassagne J, et al. Successful blood stem cell collection and transplant in children weighing less than 25 kg. Bone Marrow Transplant 1994;13:43-50.
14. Kanold J, Hall P, Rapatel C, et al. Efficient and safe PBSC collection in children (abstract). Med Pediatr Oncol 1996;27(Suppl 1):249a.
15. Haut P, Olsewski M, Kletzel M. Autologous peripheral blood stem cell transplantation in children (abstract). Med Pediatr Oncol 1996;27(Suppl 1):259a.
16. Diaz MA, Alegre A, Villa M, et al. Pediatric experience with autologous peripheral blood progenitor cell transplantation: influence of CD34+ cell dose in engraftment kinetics. Bone Marrow Transplant 1996;18:699-703.
17. Fischer J, Unkrig C, Ackerman M, et al. Intra-day CD34+ cell counts depend on the time to application and correlate with the resulting G-CSF plasma level after steady-state mobilization of PBPC by filgrastim (abstract). Blood 1994;84(Suppl 1):81a.